EFFECTS OF MORPHINE ON METHOTREXATE DISPOSITION IN MICE

1. Morphine has been shown to slow the renal excretion of other drugs. The present study in mice evaluated the effects of morphine on the disposition of methotrexate (MTX), an antimetabolite eliminated by the kidneys.

[1]  L. Sierrasesúmaga,et al.  Pharmacodynamics of High-Dose Methotrexate in Pediatric Patients , 2002, The Annals of pharmacotherapy.

[2]  M. Erion,et al.  Isolation of a family of organic anion transporters from human liver and kidney. , 2001, Biochemical and biophysical research communications.

[3]  B. Kimler,et al.  Opiate effects on 5-fluorouracil disposition in mice , 1996, Cancer Chemotherapy and Pharmacology.

[4]  S. Masuda,et al.  Cloning and Functional Characterization of a Novel Rat Organic Anion Transporter Mediating Basolateral Uptake of Methotrexate in the Kidney* , 1996, The Journal of Biological Chemistry.

[5]  G. Dibona,et al.  Role of endogenous peripheral opioid mechanisms in renal function. , 1994, Journal of the American Society of Nephrology : JASN.

[6]  R. Portenoy,et al.  Cancer pain management current strategy , 1993, Cancer.

[7]  J. Antunes-Rodrigues,et al.  Role of opioid peptides and subfornical organ in the renal function of intact and hypophysectomized rats , 1992, Physiology and Behavior.

[8]  L. Walker,et al.  Effects of morphine on the renal handling of sodium and lithium in conscious rats. , 1990, The Journal of pharmacology and experimental therapeutics.

[9]  S. Danesh,et al.  Effects of central administration of morphine on renal function in conscious rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[10]  A. Hurwitz,et al.  A novel acute toxicity resulting from the administration of morphine and adriamycin to mice. , 1987, Toxicology and applied pharmacology.

[11]  M. Garty,et al.  Tolerance to morphine effects on renal disposition of xenobiotics in mice. , 1986, The Journal of pharmacology and experimental therapeutics.

[12]  Z. Ben-Zvi,et al.  Effects of morphine and clonidine on sulphobromophthalein disposition in mice , 1986, The Journal of pharmacy and pharmacology.

[13]  L. Walker,et al.  Effect of renal denervation on the antinatriuretic response to morphine administration in conscious rats. , 1986, Journal of Pharmacology and Experimental Therapeutics.

[14]  A T Florence,et al.  The effect of niosomes and polysorbate 80 on the metabolism and excretion of methotrexate in the mouse. , 1986, Journal of microencapsulation.

[15]  Z. Ben-Zvi,et al.  Opioid effects on hepatic disposition of dyes in mice. , 1985, The Journal of pharmacology and experimental therapeutics.

[16]  W. M. Williams,et al.  Effect of penicillin on the renal tubular secretion of methotrexate in the monkey. , 1984, Cancer research.

[17]  Mei-ling Chen,et al.  Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits after intravenous administration , 1983, Journal of Pharmacokinetics and Biopharmaceutics.

[18]  A. Hurwitz,et al.  Narcotic effects on hepatic disposition of sulfobromophthalein in rats. , 1983, The Journal of pharmacology and experimental therapeutics.

[19]  H. Breithaupt,et al.  Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate. , 1982, Cancer treatment reports.

[20]  S. Vatner,et al.  Morphine Effects on Cardiac Output and Regional Blood Flow Distribution in Conscious Dogs , 1981, Anesthesiology.

[21]  J. Mcvie,et al.  Dose dependent methotrexate elimination following bolus intravenous injection , 1980, European Journal of Clinical Pharmacology.

[22]  K. Huang,et al.  Renal tubular transport of methotrexate in the rhesus monkey and dog. , 1979, Cancer research.

[23]  W. F. White,et al.  Prolongation and enhancement of serum methotrexate concentrations by probenecid. , 1978, British medical journal.

[24]  J. Aroesty,et al.  Pharmacokinetics of high-dose methotrexate with citrovorum factor rescue. , 1977, Cancer treatment reports.

[25]  G. Rosen,et al.  High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity. , 1977, Cancer treatment reports.

[26]  B. Chabner,et al.  7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate. , 1976, The Journal of clinical investigation.

[27]  W. Daggett,et al.  Cardiovascular response to large doses of intravenous morphine in man. , 1969, The New England journal of medicine.

[28]  E. Henderson,et al.  The effect of organic acids on renal clearance of methotrexate in man , 1969, Clinical pharmacology and therapeutics.

[29]  E J Freireich,et al.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. , 1966, Cancer chemotherapy reports.

[30]  D. S. Gibbs.  Manual of Pharmacology , 1937, Nature.

[31]  H. Iven,et al.  Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits , 2004, Cancer Chemotherapy and Pharmacology.

[32]  H. Iven,et al.  Pharmacokinetics of methotrexate (MTX) and 7-hydroxymethotrexate (7-OH-MTX) in rats and evidence for the metabolism of MTX to 7-OH-MTX , 2004, Cancer Chemotherapy and Pharmacology.

[33]  Mark J. Reasor,et al.  Principles of Toxicology , 2003 .

[34]  E. Scheufler.  Evidence of nonlinear pharmacokinetics of methotrexate in the rat. , 1982, Pharmacology.

[35]  A. Hurwitz.  Narcotic effects on phenol red disposition in mice. , 1981, The Journal of pharmacology and experimental therapeutics.

[36]  W. Sadee,et al.  Methotrexate and 7-hydroxymethotrexate: serum level monitoring by high-performance liquid chromatography. , 1980, Cancer treatment reports.

[37]  Leon Shargel,et al.  Applied biopharmaceutics and pharmacokinetics , 1980 .

[38]  A. Calvert,et al.  Some observations on the human pharmacology of methotrexate. , 1977, Cancer treatment reports.

[39]  C. Barnes,et al.  Drug dosage in laboratory animals : a handbook , 1964 .